Assessment of acute coronary syndromes: focus on novel biomarkers.
Coronary artery disease (CAD) is the leading cause of mortality in Western Societies and several developing countries. Recent evidence suggests that most detrimental clinical manifestations of CAD, such as acute coronary syndromes (ACS), are the outcome of inflammatory processes that lead to plaque...
Auteurs principaux: | Tousoulis, D, Hatzis, G, Papageorgiou, N, Androulakis, E, Bouras, G, Giolis, A, Bakogiannis, C, Siasos, G, Latsios, G, Antoniades, C, Stefanadis, C |
---|---|
Format: | Journal article |
Langue: | English |
Publié: |
2012
|
Documents similaires
-
From atherosclerosis to acute coronary syndromes: the role of soluble CD40 ligand.
par: Tousoulis, D, et autres
Publié: (2010) -
Matrix metalloproteinases in acute coronary syndromes: current perspectives.
par: Kampoli, A, et autres
Publié: (2012) -
The impact of statin administration in acute coronary syndromes.
par: Papageorgiou, N, et autres
Publié: (2010) -
C-reactive protein and endothelial dysfunction: Gazing at the coronaries
par: Tousoulis, D, et autres
Publié: (2011) -
C-reactive protein and endothelial dysfunction: gazing at the coronaries.
par: Tousoulis, D, et autres
Publié: (2011)